FDA-Approved Alternatives to Premarin and Prempro

Clinical Update on the Safe and Effective Use of Biodentical Hormones for Menopausal Hormone Therapy.  Presented by The American Journal of Obstetrics and Gynecology in association with the Bioidentical Hormone Initiative.

Learning Objectives:

  • Understand the physiologic and morphologic differences between synthetic and bioidentical hormones
  • Summarize recent scientific research surrounding the safety and efficacy of Bioidentical Hormone Therapy
  • Understand how to prescribe FDA-approved bioidentical hormone options
  • Assess expert opinion regarding optimal use of Bioidentical Hormone Therapy for patients with certain menopause-related symptoms, including the use of transdermal therapy versus oral medications

Please install the Flash Plugin

1.Review and Sponsorship: 

The content posted on this webcast has been reviewed and approved by the American Journal of Obstetrics and Gynecology. Author disclosure statements for the presenters are accessible on this webpage (see Faculty Disclosures). Posting of this educational content was supported by a grant from Ascend Therapeutics, Inc. 

2. Faculty list: 

Moderator: 

Monique Fayad 
Medical Communications Director, Bioidentical Hormone Initiative 

Speakers: 

Erika Schwartz, MD 
CMO, AgeMD.org, Director, Bioidentical, Hormone Initiative 

Kent Holtoft, MD 
Holtorf Medical Institute, Director, Bioidentical, Hormone Initiative 

Arthur Prancan, PhD 
Pharmacology Chairman, Touro College of Osteopathic Medicine 

3. Faculty Disclosures 

  • Monique Fayad has no industry financial relationships to disclose. 
  • Erika Schwartz has no industry financial relationships to disclose. 
  • Kent Holtoft has no industry financial relationships to disclose. 
  • Arthur Prancan has no industry financial relationships to disclose.

4. Disclaimer: 

Disclosure Statement of the Sponsor 
Posting of this webcast is made possible by support from Ascend Therapeutics, Inc. 

Statement of Peer Review 
The content of this webcast has been reviewed and approved for posting by an outside peer reviewer and the journal editorial office. Author disclosure statements for the presenters are accessible on this webpage (see Faculty Disclosures). 

Disclaimer Statement 
The opinions or views expressed in this webcast are those of the presenters and do not necessarily reflect the opinions and recommendations of the publisher, the American Journal of Obstetrics and Gynecology, guest editors, or supporters. Presenters may discuss pharmaceutical products and/or use of products that have not been approved by the US Food and Drug Administration or other regulatory authorities outside the United States. Dosages, indication, and methods of use for compounds that are referred to by the presenters may reflect their clinical experience or may be derived from the professional literature or other sources. For approved product information, consult the manufacturer's prescribing information or the applicable regulatory authority. 

   

Online Training

With BHI Online's Education & Online Training you can be amongst the first to hear about landmark research, clinical insights benefits of bioidentical hormone & other therapies.
Read more...

Resources

BHI Online houses an archive of hormone-related citations for biomedical literature. Also provided are links to PubMed and the NCBI molecular biology resources.
Read more...

Webinars

BHI Online strives to support healthcare professionals through webinars presented by leading experts in their respective fields.
Read more...

Forums

Join the conversation with BHI Online's forums aimed at providing information through communities.
Read more...

Latest News

A selection of stories and articles making headlines in the field of Bioidentical Hormone therapies.
Read more...

Get In Touch

Locate a BHRT doctor, submit an article or just say hello, we'd love to meet you.
Read more...

Sub Page: Side Block 0

Sub Page: Side Block 1

Sub Page: Side Block 2

Sub Page: Side Block 3

Sub Page: Side Block 4